Li Dongping, Ilnytskyy Yaroslav, Kovalchuk Anna, Khachigian Levon M, Bronson Roderick T, Wang Bo, Kovalchuk Olga
Department of Biological Sciences, University of Lethbridge, Lethbridge, Canada.
Oncotarget. 2013 Sep;4(9):1373-87. doi: 10.18632/oncotarget.1165.
Transcriptional regulation of miRNAs that control the pathogenesis of breast cancer remains largely unknown. Here, we showed that ionizing radiation, a known breast carcinogen, triggered the differential expression of miR-20b in mammary tissues. We identified several GC-rich consensus binding motifs for the zinc finger transcription factor early growth response-1 (EGR1) in miR-20b promoter. miR-20b was upregulated by IR and its upregulation correlated with EGR1 expression in the breast cancer cell line HCC1806. Therefore, we used HCC1806 cells as a model system to explore the role of EGR1 in miR-20b transcription. siRNA knockdown of EGR1 attenuated miR-20b expression. Luciferase assays showed that whereas EGR1 stimulated luciferase activity driven by the wild-type miR-20b promoter, this induction was abolished in the mutant miR-20 promoter construct. We noted significant enrichment of EGR1 at miR-20b promoter in HCC1806 cells compared with normal human mammary epithelial cells. Suppression of miR-20b significantly inhibited HCC1806 cell proliferation and migration, and led to G0/G1 and S phase arrest. In vitro RNA-pull down assays indicated that miR-20b targets numerous tumor suppressors, including PTEN and BRCA1, which were downregulated in HCC1806. Conversely, suppression of miR-20b increased PTEN and BRCA1 levels. Moreover, immunohistochemical and FISH analyses showed that the miR-20b expression correlated significantly with EGR1 levels in breast cancer tissues. Our findings thus demonstrate for the first time that EGR1 is a key player in the transcriptional control of miR-20b, and miR-20b may in turn function as an oncogene by contributing to breast tumorigenesis via tumor suppressor targeting.
控制乳腺癌发病机制的微小RNA(miRNA)的转录调控在很大程度上仍不清楚。在此,我们发现,已知的乳腺癌致癌物电离辐射可引发乳腺组织中miR-20b的差异表达。我们在miR-20b启动子中鉴定出了锌指转录因子早期生长反应-1(EGR1)的几个富含GC的共有结合基序。miR-20b在电离辐射后上调,其上调与乳腺癌细胞系HCC1806中的EGR1表达相关。因此,我们使用HCC1806细胞作为模型系统来探究EGR1在miR-20b转录中的作用。通过小干扰RNA(siRNA)敲低EGR1可减弱miR-20b的表达。荧光素酶检测表明,EGR1可刺激由野生型miR-20b启动子驱动的荧光素酶活性,但在突变型miR-20启动子构建体中这种诱导作用消失。我们注意到,与正常人乳腺上皮细胞相比,HCC1806细胞中EGR1在miR-20b启动子处显著富集。抑制miR-20b可显著抑制HCC1806细胞的增殖和迁移,并导致细胞停滞在G0/G1期和S期。体外RNA下拉实验表明,miR-20b靶向许多肿瘤抑制因子,包括PTEN和BRCA1,这些因子在HCC1806中表达下调。相反,抑制miR-20b可增加PTEN和BRCA1的水平。此外,免疫组织化学和荧光原位杂交分析表明,miR-20b的表达与乳腺癌组织中的EGR1水平显著相关。因此,我们的研究结果首次证明,EGR1是miR-20b转录调控的关键因子,而miR-20b反过来可能通过靶向肿瘤抑制因子促进乳腺肿瘤发生而发挥癌基因的作用。